contraindications for tirzepatide Mounjaro (Tirzepatide) Medical Weight Loss in Fayetteville, NC Tirzepatide vs Mounjaro: What's the
Description
Aims/hypothesis Tirzepatide is a novel dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) currently under review for marketing approval
Methods We selected individuals aged 45 years and older already treated with metformin living in Lombardy, Italy, and then split them into two groups if they initiated GLP-1 RAs or other antidiabetic drugs, between 2019 and 2021
The Medicine Prize will be announced first
Results Fifty patients (82% female) were included
Here we ...
